Safety and Efficacy of MILEP Versus Standard EEP

ConditionsBenign Prostate Hypertrophy(BPH)LUTS(Lower Urinary Tract Symptoms)

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexMale

Age18-85

SponsorSechenov University

About this trial

Endoscopic enucleation of the prostate (EEP) is a standard treatment for benign prostatic hyperplasia (BPH), with modifications such as MiLEP that utilizes smaller instruments. The reduced resectoscope diameter in MiLEP may help decrease rates of stress urinary incontinence (SUI) and urethral strictures.

Objective: to compare the efficacy and safety of MiLEP and standard EEP with a thulium fiber laser (TFL).

Eligibility criteria

Qualifiers

IPSS questionnaire (Score >20);

OR uroflowmetry result (Qmax <10 ml/s);

Disqualifiers

Prostate volume > 120 cc

Prostate cancer on pathology;

Urethral strictures;

Bladder calculi;

Trial design

Treatments tested in this trial

Standard endoscopic enucleation of the prostate (EEP)
MiLEP

Treatment groups

340 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Sechenov University

Lead sponsor

Hospital Pompeia

Collaborator

Source ClinicalTrials.gov